Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3452578)

Published in Indian J Surg on July 30, 2008


Rajeev Sharma1, M R Rajasekar, Arun Raghuvanshi

Author Affiliations

1: Dept. of Hepatobiliary Surgery and Multiorgan Transplant, Indraprastha Apollo Hospitals, Mathura Road, New Delhi, India.

Articles cited by this

A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med (1994) 4.22

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet (1994) 3.72

A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation (1996) 2.61

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl (2004) 1.06

Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy (1989) 1.06

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Transplantation (1997) 0.99

Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl (2005) 0.98

Options for induction immunosuppression in liver transplant recipients. Drugs (2002) 0.96

Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. Transplant Proc (1997) 0.96